1Pfeffer JM, Fischer TA, Pfeffer MA. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol, 1995,57 ( 3 ) :808-826.
2Nomoto T, Nishina T, Miwa S,et al. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats. Circulation,2002,106 ( 12 Suppl 1 ) : 1115-1119.
3Patten RD,Aronovitz MJ,Einstein M,et al. Effects of angiotensin Ⅱ receptor blockade versus angiotensin-converting enzyme inhibition on ventricular remodeling following myocardial infarction in the mouse.Clin Sci ( Lond ) ,2003,04 ( 2 ) : 1009-1018.
4Mankad S,d Amato TA, Reichek N, et al. Combined angiotensin Ⅱ receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling. Circulation ,2001,103 ( 23 ) :2845-2850.
5Cavasin MA,Yang XP,Liu YH,et al. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure. J Cardiovasc Pharmacol,2000,36 (4) :472-480.
6Richer C,Gervais M,Fones P,et al. Combined selective angiotensin Ⅱ AT1 -receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats.J Cardiovasc Pharmacol, 1999,34 ( 6 ) : 772-781.
7Nakamura Y, Yoshiyama M, Omura T, et al. Beneficial effects of combination of ACE inhibitor and angiotensin Ⅱ type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc Res,2003,57( 1 ) :48-54.
8Liu YH, Yang XP, Mehta D, et al. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogendeficient rats. Am J Physiol Heart Circ Physiol, 2000,278 ( 2 ) :H507-514.